Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H H Soep

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Journal of Antimicrobial Chemotherapy|July 1, 1981
Influence of age and renal disease on aminoglycoside dosageT Hallynck, H H Soep, L Dettli
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|November 21, 1978
[Aminoglycosides, renal toxicity and enzymes (author's transl)]H H Soep, M E de Broe
British Journal of Clinical Pharmacology|February 1, 1982
Creatinine clearance, different methods of determinationJ A Thomis, H H Soep, T Hallynck, et al.
British Journal of Clinical Pharmacology|May 1, 1981
Should clearance be normalised to body surface or to lean body mass?T H Hallynck, H H Soep, J A Thomis, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1983
Reproducibility study of the pharmacokinetics of amikacin, gentamicin and tobramycin; a three-way crossover studyA Dyas, R Wise, J Pijck, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 1980
Lean body mass and amikacin dosageT H Hallynck, H H Soep, J A Thomis, et al.
Clinical Pharmacology and Therapeutics|September 1, 1981
Prediction of creatinine clearance from serum creatinine concentration based on lean body massT Hallynck, H H Soep, J Thomis, et al.
Journal of Chemotherapy (Florence, Italy)|July 1, 1989
Single-dose prophylaxis with cefotetan in elective abdominal surgery. A controlled trialJ A Gruwez, J Lerut, M R Christiaens, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Journal of Antimicrobial Chemotherapy|July 1, 1981
Influence of age and renal disease on aminoglycoside dosageT Hallynck, H H Soep, L Dettli
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|November 21, 1978
[Aminoglycosides, renal toxicity and enzymes (author's transl)]H H Soep, M E de Broe
British Journal of Clinical Pharmacology|February 1, 1982
Creatinine clearance, different methods of determinationJ A Thomis, H H Soep, T Hallynck, et al.
British Journal of Clinical Pharmacology|May 1, 1981
Should clearance be normalised to body surface or to lean body mass?T H Hallynck, H H Soep, J A Thomis, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1983
Reproducibility study of the pharmacokinetics of amikacin, gentamicin and tobramycin; a three-way crossover studyA Dyas, R Wise, J Pijck, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 1980
Lean body mass and amikacin dosageT H Hallynck, H H Soep, J A Thomis, et al.
Clinical Pharmacology and Therapeutics|September 1, 1981
Prediction of creatinine clearance from serum creatinine concentration based on lean body massT Hallynck, H H Soep, J Thomis, et al.
Journal of Chemotherapy (Florence, Italy)|July 1, 1989
Single-dose prophylaxis with cefotetan in elective abdominal surgery. A controlled trialJ A Gruwez, J Lerut, M R Christiaens, et al.
Pageof 1